modelRimegepant_Comisar2025_reference
Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral.
Information
| name: | rimegepant |
| ATC code: | N02CD06 |
| model: | two compartments, oral dosing (PK_2C_enteral) |
| source: | Comisar CM et al. 2025 |
| population: | pediatric and adult |
| measured compound: | rimegepant |
| review: | accepted with caveats |
| record page: | pharmacolibrary-docs |
Parameters as reported in the paper
| parameter | value | unit | meaning |
|---|---|---|---|
| CL/F, L/h | 25.2 | L/h | CL/F |
| V1/F, L | 113 | L | V1/F |
| V2/F, L | 46.8 | L | V2/F |
| Q/F, L/h | 4.16 | L/h | Q/F |
| k tr, 1/h | 8.42 | 1/h | ktr |
| k a, 1/h | 3.05 | 1/h | kabs |
| fed_on_f1 | -0.331 | equation variable | |
| Dose effect on F1 | 0.192 | Fab | |
| body_weight_effect_on_cl_f_and_q_f | 0.575 | equation variable | |
| theta_cl_f_hepatic | -0.410 | equation variable | |
| theta_q338_fed | -0.698 | equation variable | |
| theta_ktr_formulation | 2.19 | equation variable | |
| theta_cl_f_hepatic | -0.203 | equation variable | |
| theta_v1_f_body_weight | 1.18 | equation variable |
About rimegepant
Rimegepant is a calcitonin gene-related peptide receptor antagonist used to treat acute migraine attacks in adults. It is an approved medicine and is authorised in the European Union for migraine.
Summary written by glm-5.3-flash from Wikidata Q27272184 and the WHO ATC classification and the EMA medicines list; not checked by a person.
Identity, molar mass and metabolites: Rimegepant.
References
Comisar CM et al. (2025). Exposure Matching Using Population Pharmacokinetic Modeling and Simulation to Support Rimegepant Dose Selection for Pediatric Patients With Migraine. Clinical and translational science 18(10):e70360. DOI:10.1111/cts.70360 PUBMED:41105969
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Real | Cl_ref | 7e-06 | Cl [m3/s] |
| Real | cov_fed_0 | 0 | fed covariate |
| Real | cov_body_weight_1 | 0 | body weight covariate |
| Real | cov_hepatic_2 | 0 | hepatic covariate |
| Real | cov_hepatic_3 | 0 | hepatic covariate |
| Real | Vd_ref | 0.113 | Vd [m3] |
| Real | cov_body_weight_0 | 0 | body weight covariate |
| Modelica.Units.SI.Mass | weight (from PK_1C) | 75 | patient weight (kg) |
| Modelica.Units.SI.SpecificVolume | VdPerKg (from PK_1C) | 0.0009 | Volume of distribution per kg (default 0.9 L/kg) |
| Modelica.Units.SI.MassFraction | F (from PK_1C) | 1 | bioavailability (0-1) |
| Pharmacolibrary.Types.Clearance | Cl (from PK_1C) | 2.7777777777777776e-7 | clearance |
| Modelica.Units.SI.Time | adminTime (from PK_1C) | 60 | first administration time (s) |
| Modelica.Units.SI.Time | adminDuration (from PK_1C) | 600 | administration duration (s) |
| Modelica.Units.SI.Time | adminPeriod (from PK_1C) | 8*60*60 | period of administration (default 8 hours)(s) |
| Pharmacolibrary.Types.Mass | adminMass (from PK_1C) | 1e-4 | administration mass (mg) |
| Integer | adminCount (from PK_1C) | 8 | number of dose administered (1) |
| Pharmacolibrary.Types.Volume | Vd (from PK_1C) | VdPerKg*weight | Volume of distribution (m3) |
| Pharmacolibrary.Types.Volume | Vdp (from PK_2C) | VdpPerKg*weight | Volume of distribution (m3) |
| Modelica.Units.SI.SpecificVolume | VdpPerKg (from PK_2C) | 0.0009 | Volume of distribution peripheral per kg (default 0.9 L/kg) |
| Pharmacolibrary.Types.Clearance | k12 (from PK_2C) | 1 | intercompartmental C-P clearance |
| Pharmacolibrary.Types.Clearance | k21 (from PK_2C) | 1 | intercompartmental P-C clearance |
| Pharmacolibrary.Types.TransferRate | ka (from PK_2C_enteral) | 0.016666666666666666 | first order absorption rate |
| Modelica.Units.SI.Time | Tlag (from PK_2C_enteral) | 600 | delay between oral administration and absorption (default 10min) |
| Info › Therapeutic range (metadata, not used in equations) | |||
| Pharmacolibrary.Types.MassConcentration | Cmin (from PK_1C) | 0.004 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Cmax (from PK_1C) | 0.008 | maximal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Ctox_peak (from PK_1C) | 0.012 | toxicity peak level |
| Pharmacolibrary.Types.MassConcentration | Ctox_trough (from PK_1C) | 0.006 | toxicity trough level |
| Info › Substance metadata | |||
| Modelica.Units.SI.MolarMass | MM (from PK_1C) | 0 | molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0) |
| Info › Substance metadata (not used in equations) | |||
| Pharmacolibrary.Types.Dose | LD50 (from PK_1C) | 0 | median lethal dose [mg/kg]; 0 = unknown |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Types.ConcentrationOutput | C_central (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | centralCPort (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | peripheralCPort (from PK_2C) | ||
| Pharmacolibrary.Types.ConcentrationOutput | C_peripheral1 (from PK_2C) |
Components
| Type | Name | Default | Description |
|---|---|---|---|
| Pharmacokinetic.NoPerfusedTissueCompartment | central (from PK_1C) | ||
| Pharmacokinetic.ClearanceDrivenElimination | elim (from PK_1C) | ||
| Sources.PeriodicDose | periodicDose (from PK_1C) | ||
| Modelica.Units.SI.Time | t1_2 (from PK_1C) | central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models) | |
| Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSym | transfer (from PK_2C) | ||
| Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartment | peripheral (from PK_2C) |
Revisions
- 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Comisar_2025: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: accepted with caveats